Respondents agreed that the level of risk in pharmaceutical supply chains has increased across the board since 2023, although perceptions about the degree of escalation vary. Fifty-six (56%) percent ...
The assessment by DA Davidson reflects the ongoing battle for retail supremacy, where efficiency and speed are paramount. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback